Metabolic Syndrome

Core Definitions

Cluster of cardiovascular risk factors associated with obesity and insulin resistance.
Comprises insulin resistance, compensatory hyperinsulinemia, abdominal/visceral obesity, dyslipidemia (high triglycerides, low high-density lipoprotein), and hypertension.
Serves as precursor to type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD).
Consensus pediatric definition precludes diagnosis in children younger than 10 years.
Obesity component in children >10 years strictly defined by waist circumference, denoting intraabdominal fat accumulation.

Impact of obesity determined by specific depots of excess fat storage (lipid partitioning).
“Adipose tissue expandability” hypothesis dictates subcutaneous adipose tissue capacity exceeded.
Excess lipid shunts to ectopic tissues (liver, muscle).
Intramyocellular lipid (IMCL) and intrahepatocellular lipid (IHCL) highly predictive of insulin resistance.
Fatty acyl-CoA and diacylglycerol accumulate abnormally.
Metabolites activate serine/threonine kinase cascade (c-jun N-terminal kinase 1, protein kinase C).
Serine phosphorylation of insulin receptor substrate 1 (IRS-1) directly inhibits insulin signaling.

Selective hepatic insulin resistance occurs.
Impaired glucose homeostasis via FOXO1 pathway fails to suppress hepatic glucose output.
Normal insulin-mediated hepatic de novo lipogenesis via SREBP-1c pathway maintained.
Resultant excess triglyceride secretion, low HDL, and high small-dense LDL particles.
Skeletal muscle exhibits reduced translocation of GLUT4 to cell membrane.
Systemic glucose uptake markedly reduced.

Adipose tissue functions as active endocrine organ.
Macrophage infiltration of visceral adipose tissue elaborates inflammatory cytokines (TNF-alpha, interleukin-6).
Inflammatory cytokines initiate proinflammatory milieu predating systemic insulin resistance.
Circulating leptin levels rise significantly.
Functional leptin resistance develops, limiting satiety signals.
Adiponectin strictly reduced in obesity.
Low adiponectin inversely related to visceral adiposity, IMCL, and IHCL.
Loss of adiponectin removes crucial antiatherogenic and insulin-sensitizing effects.

Endothelial dysfunction represents earliest step in atherosclerosis development.
Characterized by decreased nitric oxide (NO) production by endothelial nitric oxide synthase (eNOS).
Elevated free fatty acids (FFAs), TNF-alpha, IL-6, and ROS inhibit eNOS.
Imbalance favors vasoconstricting factors (endothelin).
Promotes smooth muscle proliferation, adhesion of inflammatory cells, atherosclerosis, and arterial wall stiffness.
ROS generation increased via inflammatory cytokines, dysfunctional mitochondrial energetics, and glycation.

Small-for-gestational-age (SGA) and large-for-gestational-age (LGA) newborns carry inherently increased risk.
Maternal gestational diabetes exposure independently impairs fetal beta-cell function and worsens insulin resistance.

Hyperactive hypothalamus-pituitary-adrenal (HPA) axis elevates circulating cortisol.
11-beta-hydroxysteroid dehydrogenase type 1 converts inactive cortisone to active cortisol within visceral fat.
Promotes visceral adiposity (“Cushing syndrome of the abdomen”).
Sleep deprivation directly predictive of prepubertal obesity.

Dermatologic: Acanthosis nigricans (marker of hyperinsulinemia).
Hepatic: Nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH).
Reproductive: Polycystic ovarian syndrome (PCOS) characterized by anovulation, clinical/biochemical hyperandrogenism.
Respiratory: Obstructive sleep apnea (OSA) linked to endothelial dysfunction.
Vascular: Hypertension, dyslipidemia (high triglycerides, small dense LDL, low HDL).
Orthopedic: Slipped capital femoral epiphysis, Blount disease, limited mobility.

Exclude secondary dyslipidemias (hypothyroidism, nephrotic syndrome, cholestasis).
Exclude classic endocrine obesity (Cushing syndrome, growth hormone deficiency, pseudohypoparathyroidism).

Parameter	Screening Modality	Clinical Implication / Thresholds
Glucose Metabolism	Fasting glucose, OGTT, HbA1c	Prediabetes: Fasting 100-125 mg/dL, 2-hr OGTT 140-199 mg/dL, HbA1c 5.7-6.4%.
Dyslipidemia	Fasting lipid profile	Elevated LDL (>130 mg/dL), high TG (>130 mg/dL in teens), low HDL (<40 mg/dL).
Hypertension	Blood pressure	Systolic/diastolic elevation >90th percentile for age/sex/height.
Hepatic Steatosis	AST, ALT, Liver Ultrasound	Screens for NAFLD/NASH; ALT >25 U/L (boys), >22 U/L (girls) considered elevated.
PCOS	Menstrual history, Testosterone, DHEAS	Assesses clinical and biochemical hyperandrogenism.
Nephropathy	Urine albumin-to-creatinine ratio	Microalbuminuria (30-300 mg/g) indicates early vascular damage.
Sleep Apnea	Polysomnography	Assesses overnight oxygen saturation, airflow, hypoventilation.

Foundation of metabolic syndrome therapy.
Target weight loss of 7-10%.
Dietary restriction of simple sugars (<25 g/day), sugar-sweetened beverages, and processed snacks.
Saturated fat restricted to <7% of total calories.
Dietary cholesterol restricted to <200 mg/day.
Adoption of Dietary Approaches to Stop Hypertension (DASH) or Mediterranean-style diet.
Minimum 60 minutes moderate-to-vigorous physical activity daily.
Screen time strictly restricted to <2 hours daily.

Treatment Modality	Indications	Mechanism/Effect
Metformin	T2DM (>10 years), off-label for PCOS/NASH	Decreases hepatic glucose production, sensitizes peripheral tissues. Dose: 250-1000 mg PO BID.
Liraglutide	T2DM (>10 years) failing lifestyle/metformin	GLP-1 receptor agonist; enhances insulin secretion, promotes weight loss.
Orlistat	Severe obesity (>12 years)	Gastric lipase inhibitor; reduces fat absorption. Dose: 120 mg PO TID.
Statins	Persistent dyslipidemia (LDL >130-160 mg/dL)	HMG-CoA reductase inhibitors; upregulate LDL receptors, delay atherosclerosis.
Fibrates	Severe hypertriglyceridemia (TG >1000 mg/dL)	Indicated to prevent acute pancreatitis.
ACE Inhibitors / ARBs	Hypertension, Microalbuminuria	Normalize BP, delay nephropathy progression.
Bariatric Surgery	BMI >35 with severe comorbidity (T2DM, severe OSA)	Ameliorates metabolic disturbances, promotes massive weight loss. Requires multidisciplinary team.